
Omish Pharmaceuticals Private Limited
About Omish Pharmaceuticals Private Limited
Data last updated:
Omish Pharmaceuticals Private Limited was a private limited company based in Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 June 2006.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2006PTC149726. Its GSTIN is 06AAACO8567D1ZE (Haryana).
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Meenu Mahajan and Niharika Mahajan.
Its last annual general meeting (AGM) was held on 22 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at 1/7227 – I Shivaji Park Shahdara, Delhi, India – 110032.
As per the financials filed for FY 2023, the company reported a revenue of ₹2.41 Lakh, a decline of 93% compared to the previous year. For the same year it recorded a net loss of ₹59,900 (net margin -24.9%) and EBITDA of -₹59,900 (EBITDA margin -24.9%).
Company details
Contact details
Omish Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1/7227 – I Shivaji Park Shahdara, Delhi, India – 110032
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Omish Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Omish Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Omish Pharmaceuticals Private Limited, buy the company report.
Financials of Omish Pharmaceuticals Private Limited
FY 2023 filings availableOmish Pharmaceuticals Private Limited reported revenue of ₹2.41 Lakh (down 93% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 93% in the latest year. EBITDA fell 223% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹59,900 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹59,900 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -24.9% | ||||
| Net Profit Margin | -24.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Omish Pharmaceuticals Private Limited, buy the company report.
Board of directors of Omish Pharmaceuticals Private Limited
Omish Pharmaceuticals has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Meenu Mahajan | Director | 13 Aug 2008 | 18 Years 2 Months | As last reported |
| Niharika Mahajan | Additional Director | 15 Dec 2021 | 4 Years 10 Months | As last reported |
Peer comparison
Omish Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zen Mineral Chemicals Private Limited | ₹2.43 Lakh (FY 2019) | -91.0% | Navi Mumbai, Maharashtra, India | |||
| Emblem Pharmaceuticals Private Limited | ₹2.41 Lakh (FY 2025) | -58.0% | Delhi, India | |||
| Evoluent Pharmaceuticals Private Limited | ₹2.41 Lakh (FY 2021) | -55.0% | Palace Guttahalli, Karnataka, India | |||
| Omish Pharmaceuticals Private Limitedthis company | ₹2.41 Lakh (FY 2023) | -₹59,900 | -24.9% | -93.0% | Delhi, India |
To see the full peer comparison of Omish Pharmaceuticals Private Limited, buy the company report.
Auditor
Omish Pharmaceuticals Private Limited is audited by VIPUL KUMAR GOEL & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIPUL KUMAR GOEL & CO | FY 2021 | 021325N |
Shareholding
The shareholding of Omish Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Omish Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Omish Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Omish Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Omish Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAACO8567D1ZE | Haryana | Active | 01 Apr 2021 |
To see the full GST registrations and return filing status of Omish Pharmaceuticals Private Limited, buy the company report.
Recent activity
Omish Pharmaceuticals Private Limited has 8 board changes on record since 2007: 2 appointments and 6 cessations. The latest: Niharika Mahajan was appointed as Additional Director on 15 Dec 2021.
Frequently asked questions
Omish Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Omish Pharmaceuticals was a private limited company based in Delhi, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 14 June 2006 and is registered under CIN U24233DL2006PTC149726. The company has been struck off by the Registrar of Companies and is no longer operational.
Omish Pharmaceuticals had 2 directors:
- Meenu Mahajan - Director
- Niharika Mahajan - Additional Director
The CIN (Corporate Identification Number) of Omish Pharmaceuticals is U24233DL2006PTC149726. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Omish Pharmaceuticals is at 17227 – I Shivaji Park Shahdara, Delhi, India – 110032.
Omish Pharmaceuticals was incorporated on 14 June 2006. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Omish Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 22 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Omish Pharmaceuticals is 06AAACO8567D1ZE, registered in Haryana.
Omish Pharmaceuticals operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.
The peers of Omish Pharmaceuticals by revenue are Zen Mineral Chemicals Private Limited, Emblem Pharmaceuticals Private Limited, Evoluent Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Niharika Mahajan was appointed as Additional Director on 15 Dec 2021. Ashish Gupta ceased to be Director on 08 Nov 2021. Anju Bala ceased to be Director on 24 Sep 2013. Omish Pharmaceuticals has 8 board changes on record in total.